You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 185 No. 11, September 14, 1963 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Methyldopa and Hydrochlorothiazide in Primary Hypertension

Controlled Clinical Trial of Drugs Singly and in Combination

William R. Wilson, MD; Ronald Okun, MD; Leon Tetreault, MD; Norma Fallis, MD

JAMA. 1963;185(11):819-825.


Abstract

Forty-five hypertensive patients were given hydrochlorothiazide for 1 month and were then allocated at random to one of three treatment groups: methyldopa and hydrochlorothiazide, methyldopa alone, or hydrochlorothiazide alone. Combination of hypotensive drugs reduced supine mean arterial pressure more effectively than methyldopa alone. Methyldopa and hydrochlorothiazide may have a slightly greater depressor effect on supine blood pressure than a thiazide alone, but the difference was not statistically significant in this study. Combination produced a significantly greater decrease in standing mean arterial pressure than did either drug alone. Pulse rate was modestly reduced in patients who received methyldopa. The mild increase in body weight after methyldopa alone was not seen in the other two groups. Serious toxicity was not observed in this short-term trial.



Author Affiliations

Baltimore

From the Division of Clinical Pharmacology, Department of Medicine, the Johns Hopkins School of Medicine. This work was completed while Dr. Wilson was a Traveling Fellow of the College of Medicine, State University of Iowa, Iowa City. He is now at the State University of Iowa.


Footnotes

Read in part at the Annual Meeting of the Central Society for Clinical Research, Chicago, Nov 2, 1962.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of an Antihypertensive Agent: Comparison of Methyldopa and Hydrochlorothiazide in Combination and Singly
McMahon
JAMA 1975;231:155-158.
ABSTRACT  

Hypertension--Primary and Secondary
KAUFMAN et al.
ANN INTERN MED 1971;75:761-776.
ABSTRACT  

Furosemide in Essential Hypertension: A Statistical Analysis of Three Double-Blind Studies
Wertheimer et al.
Arch Intern Med 1971;127:934-938.
ABSTRACT  

Co-operative Clinical Trial of Alpha-methyldopa: III. Double-blind Control Comparison of Alpha-methyldopa and Chlorothiazide, and Chlorothiazide and Rauwolfia
SMITH et al.
ANN INTERN MED 1966;65:657-671.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.